Invesco Ltd. Ani Pharmaceuticals Inc Transaction History

Invesco Ltd.

$600 Billion
Q3 2025

A detailed history of Invesco Ltd. transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Invesco Ltd. holds 150,658 shares of ANIP stock, worth $12.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

150,658

Previous 172,457 12.64%

Holding current value

$12.7 Million

Previous $11.3 Million 22.64%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$63.35 - $98.81 $1.38 Million - $2.15 Million	-21,799 Reduced 12.64%	150,658 $13.8 Million
Q2 2025 Aug 13, 2025	SELL	$57.79 - $72.95 $1.57 Million - $1.98 Million	-27,110 Reduced 13.58%	172,457 $11.3 Million
Q1 2025 May 12, 2025	BUY	$53.93 - $68.36 $109,046 - $138,223	2,022 Added 1.02%	199,567 $13.4 Million
Q4 2024 Feb 13, 2025	SELL	$53.35 - $61.74 $1.22 Million - $1.41 Million	-22,814 Reduced 10.35%	197,545 $10.9 Million
Q3 2024 Nov 12, 2024	SELL	$54.33 - $65.72 $4.93 Million - $5.96 Million	-90,732 Reduced 29.17%	220,359 $13.1 Million

Q2 2024 Aug 13, 2024	SELL	$58.53 - $68.82 $758,022 - $891,287	-12,951 Reduced 4.0%	311,091 $19.8 Million
Q1 2024 May 14, 2024	BUY	$54.2 - $69.69 $3.56 Million - $4.57 Million	65,596 Added 25.38%	324,042 $22.4 Million
Q4 2023 Feb 12, 2024	SELL	$48.72 - $65.43 $3.96 Million - $5.32 Million	-81,289 Reduced 23.93%	258,446 $14.3 Million
Q3 2023 Nov 13, 2023	BUY	$50.28 - $64.61 $11.1 Million - $14.3 Million	220,690 Added 185.38%	339,735 $19.7 Million
Q2 2023 Aug 11, 2023	BUY	$37.29 - $53.83 $1.97 Million - $2.85 Million	52,953 Added 80.12%	119,045 $6.41 Million
Q1 2023 May 12, 2023	SELL	$37.61 - $45.72 $240,139 - $291,922	-6,385 Reduced 8.81%	66,092 $2.63 Million
Q4 2022 Feb 13, 2023	BUY	$31.9 - $41.95 $210,635 - $276,995	6,603 Added 10.02%	72,477 $2.92 Million
Q3 2022 Nov 14, 2022	SELL	$29.83 - $38.01 $249,259 - $317,611	-8,356 Reduced 11.26%	65,874 $2.12 Million
Q2 2022 Aug 15, 2022	BUY	$23.09 - $33.46 $91,852 - $133,103	3,978 Added 5.66%	74,230 $2.2 Million
Q1 2022 May 16, 2022	BUY	$26.91 - $47.15 $22,685 - $39,747	843 Added 1.21%	70,252 $1.98 Million
Q4 2021 Feb 14, 2022	SELL	$32.97 - $56.85 $59,741 - $103,012	-1,812 Reduced 2.54%	69,409 $3.2 Million
Q3 2021 Nov 15, 2021	SELL	$26.48 - $35.99 $45,439 - $61,758	-1,716 Reduced 2.35%	71,221 $2.34 Million
Q2 2021 Aug 17, 2021	BUY	$31.86 - $38.6 $89,016 - $107,848	2,794 Added 3.98%	72,937 $2.56 Million
Q1 2021 May 17, 2021	BUY	$28.4 - $36.14 $271,447 - $345,426	9,558 Added 15.78%	70,143 $2.54 Million
Q4 2020 Feb 16, 2021	SELL	$23.69 - $31.47 $323,581 - $429,848	-13,659 Reduced 18.4%	60,585 $1.76 Million
Q3 2020 Nov 16, 2020	SELL	$26.38 - $33.1 $67,875 - $85,166	-2,573 Reduced 3.35%	74,244 $2.09 Million
Q2 2020 Aug 14, 2020	SELL	$29.93 - $50.1 $5.67 Million - $9.48 Million	-189,279 Reduced 71.13%	76,817 $2.49 Million
Q1 2020 May 15, 2020	SELL	$30.35 - $67.14 $2.98 Million - $6.6 Million	-98,294 Reduced 26.97%	266,096 $10.8 Million
Q4 2019 Feb 14, 2020	BUY	$55.65 - $79.83 $9.05 Million - $13 Million	162,577 Added 80.56%	364,390 $22.5 Million
Q3 2019 Nov 14, 2019	SELL	$64.7 - $85.39 $804,026 - $1.06 Million	-12,427 Reduced 5.8%	201,813 $14.7 Million
Q2 2019 Aug 14, 2019	BUY	$67.77 - $82.2 $7.73 Million - $9.38 Million	114,084 Added 113.91%	214,240 $17.6 Million
Q1 2019 May 15, 2019	SELL	$45.83 - $70.54 $655,369 - $1.01 Million	-14,300 Reduced 12.49%	100,156 $7.07 Million
Q4 2018 Feb 14, 2019	BUY	$41.17 - $56.44 $4.71 Million - $6.46 Million	114,456 New	114,456 $5.15 Million

Others Institutions Holding ANIP

# of Institutions

283

Shares Held

20.5M

Call Options Held

30.6K

Put Options Held

30.7K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.46B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account